Record Details

Catalog Search

Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017.

Available copies

  • 1 of 1 copy available at Evergreen Indiana.

Current holds

0 current holds with 1 total copy.

Show Only Available Copies
Location Call Number / Copy Notes Barcode Shelving Location Status Due Date
Indiana State Library - Indianapolis ISLM Y 4.C 73/8:115-10 (Text) 00000106817455 General Federal documents Available -

Record details

  • Physical Description: v, 136 pages : illustrations ; 24 cm
  • Publisher: Washington : U.S. Government Publishing Office, 2018.

Content descriptions

General Note:
Shipping list no.: 2019-0072-P.
"Serial No. 115-10."
Bibliography, etc. Note:
Includes bibliographical references.
Subject: United States. Food and Drug Administration > Rules and practice.
Generic drugs > Prices > United States.
Prescription pricing > Law and legislation > United States.
User charges > Law and legislation > United States.
Drug accessibility > Government policy > United States.
Drugs > Law and legislation > United States.

Additional Resources